1-(4-Bromophenyl)cyclobutanecarboxylic acid, 95.0%, 25g

n-Butyldimethylmethoxysilane, 97%, 100g

(R)-2-Amino-5-((tert-butoxycarbonyl)amino)pentanoic acid, 95.0%, 10g

4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)tetrahydro-2H-pyran-4-carboxylic acid, 95.0%, 250mg

(1S,2S)-N1,N2-Dimethyl-1,2-bis(4-(trifluoromethyl)phenyl)ethane-1,2-diamine, 97%, 250mg

Methyl 1-methyl-4-nitro-1H-pyrazole-5-carboxylate, 95.0%, 25g

4-Bromoacetyl-5-methyl-3-phenylisoxazole, 95.0%, 1g

tert-Butyl (4-fluoropyrrolidin-3-yl)carbamate, 95.0%, 250mg

2-chlorooctanal, 95.0%, 250mg

6-Fluoro-7-nitroquinoxaline, 98%, 10g

1-(2-Methyl-2H-pyrazol-3-yl)-ethanone, 95.0%, 250mg

Trial kit Spectra/Por® 1-3 Spectra/Por® 1 – MWCO 6000–8000, 32 mm, 1 Piece(s)

3-Vinylthiophene, 95% mix TBC as stabilizer, 100mg